Quality Statistics
Congestive Heart Failure (CHF): How do we compare?
At Community Hospital Anderson, we take pride in the care we provide to our patients. To monitor the quality of that care, we track specific quality measures and compare them to benchmark measures. We publish this information so that you can see how effective Community Hospital Anderson is on the treatment of CHF.
|
% Inpatient readmissions for CHF patients |
CHA 2004 |
CHA 2005 |
National |
8.1% |
7.1% |
23% |
Approximately five million people in the United States have congestive heart failure (CHF), in which the weakened heart cannot pump blood to pump enough blood to body organs. Although CHF affects patients' health in many ways, proper care can improve both quality and length of life. A low rate of readmission to the hospital within 30 days for the same or related condition is one indicator of quality care in the hospital and of quality follow-up care after dismissal. Our Healthy Hearts Clinic is a factor in helping patients with outpatient care. CHA should be at or below the national benchmark. |
|
|
Average length of stay for CHF patients |
CHA 2004 |
CHA 2005 |
National |
4.14 |
3.96 |
4.39 days |
This indicator measures the average number of days CHF patients are hospitalized during each inpatient stay. Length of stay is one indicator a hospital should consider in determining if it is using resources for inpatient care appropriately. CHF average length of stay should be close to the national benchmark. |
|
|
CHF inpatient mortality |
CHA 2004 |
CHA 2005 |
National |
3.0% |
3.7% |
< 7.5% |
Inpatient mortality measures the percentage of inpatient deaths among all CHF patients admitted to Community Hospital. CHA mortality rate should be near or below the national benchmark. |
|
|
CHF patients on ACE or ARBs at discharge |
CHA 2004 |
CHA 2005 |
State |
95.8% |
97.0% |
76.0% |
Medications beneficial to many CHF patients are angiotensin-converting enzyme (ACE) inhibitors or angiotensin-receptor blockers (ARBs). ACE inhibitors and ARBs have been shown to lower mortality and improve functional capacity and quality of life. CHA should be at or greater than the state benchmark |
|
|
